Haleon (HLN) Total Debt (2021 - 2025)
Haleon (HLN) posted Total Debt of $11.5 billion for Q4 2025, down 11.9% on a QoQ basis from $13.0 billion in Q4 2024, and down 11.9% year-over-year from $13.0 billion in Q4 2024.
Haleon (HLN) Total Debt (2021 - 2025) Analysis & Trends
Haleon's Total Debt history runs 5 years deep, the most recent figure standing at $11.5 billion for Q4 2025.
- Quarterly Total Debt fell 11.9% year-over-year to $11.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.5 billion (down 11.9% YoY) and the FY2025 annual result came in at $11.4 billion, down 12.31% from the prior year.
- Total Debt was $11.5 billion for Q4 2025 at Haleon, down from $13.0 billion in the prior quarter.
- Across five years, Total Debt topped out at $13.0 billion in Q4 2024 and bottomed at -$12.5 billion in Q2 2022.
- A 5-year average of $2.0 billion and a median of $5.8 billion in 2021 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt soared 5372.31% — and 2025, when it fell 11.9%.
- Haleon's Total Debt stood at $223.8 million in 2021, then surged by 5372.31% to $12.2 billion in 2022, then declined by 4.16% to $11.7 billion in 2023, then grew by 10.75% to $13.0 billion in 2024, then declined by 11.9% to $11.5 billion in 2025.
- Business Quant data shows HLN's Total Debt at $11.5 billion in Q4 2025, $13.0 billion in Q4 2024, and -$9.3 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 198.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.45 Bn |
| Dec 31, 2024 | 13.00 Bn |
| Jun 30, 2024 | -9.35 Bn |
| Dec 31, 2023 | 11.74 Bn |
| Jun 30, 2023 | -10.97 Bn |
| Dec 31, 2022 | 12.25 Bn |
| Jun 30, 2022 | -12.49 Bn |
| Dec 31, 2021 | 223.77 Mn |